November 23, 2009 (FinancialWire) — Becton, Dickinson and Co. (NYSE: BDX) has closed its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.

In May 2009, BD and HandyLab announced an exclusive agreement for BD to develop and commercialize molecular assays on the HandyLab Jaguar platform, an integrated molecular diagnostic system designed to provide hands-off operation, incorporating clinical sample preparation, nucleic acid extraction, and microfluidic real-time polymerase chain reaction amplification and detection in a bench-top system.

The self-contained workstation is designed to accommodate both batch workflows and on-demand testing for maximum lab efficiency and flexibility.

With the acquisition, BD will migrate its BD GeneOhm molecular assays for Methicillin-resistant Staphylococcus aureus, Clostridium difficile and Vancomycin-resistant Enterococcus onto the new platform and will market them as the new BD MAX system, an evolution of the current Jaguar system.

Franklin Lakes, New Jersey-based Becton, Dickinson is a global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. BD employs approximately 29,000 associates in approximately 50 countries throughout the world.

The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.